Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL804987 | 0.87 | MAPT (0.40) | PLA2G10PLA2G2APLA2G4ANPC1MAPT | |
| SCHEMBL805987 | 0.86 | PLA2G10 (0.31) | PLA2G10PLA2G2APLA2G4A | |
| SCHEMBL22487614 | 0.86 | PLA2G2A (0.37) | PLA2G10PLA2G2APLA2G4A | |
| SCHEMBL804869 | 0.84 | MAPT (0.42) | PLA2G10PLA2G2APLA2G4ANPC1MAPT | |
| SCHEMBL21993183 | 0.83 | PLA2G2A (0.38) | PLA2G10PLA2G2APLA2G4A | |
| SCHEMBL804971 | 0.82 | MAPT (0.40) | PLA2G10PLA2G2APLA2G4ANPC1MAPT | |
| SCHEMBL21426315 | 0.82 | PLA2G2A (0.44) | PLA2G10PLA2G2APLA2G4ANPC1MAPT | |
| SCHEMBL12175598 | 0.82 | PLA2G2A (0.33) | PLA2G10PLA2G2APLA2G4A | |
| SCHEMBL19054200 | 0.82 | PLA2G2A (0.38) | PLA2G10PLA2G2APLA2G4A | |
| SCHEMBL15889121 | 0.81 | MAPT (0.40) | PLA2G10PLA2G2APLA2G4ANPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120068164-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120068164-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | EMC2, L1CAM, EMC1 | PLA2G10 3693/4885PLA2G2A 2297/4885PLA2G4A 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.